MEI Pharma (NASDAQ:MEIP) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a research report sent to investors on Friday morning. The firm issued a buy rating on the stock. Other equities research analysts have also recently issued reports about the company. Laidlaw cut MEI Pharma from a buy rating to a hold rating […]

Leave a Reply

Your email address will not be published.

Previous post Disc Medicine (NASDAQ:IRON) Earns Overweight Rating from Cantor Fitzgerald
Next post RadNet (NASDAQ:RDNT) PT Raised to $80.00